How to Read a VC Term Sheet: A Clause-by-Clause Guide

To read a VC term sheet, sort every clause into three groups: economics (how exit proceeds are split), control (who decides what), and future financing (what happens in the next round). Then model the payout to common stockholders at three exit values, low, middle and high, because the same headline valuation can produce very different results depending on structure. Most terms only matter in the middle outcomes, which is where most companies end up.

A real case shows the stakes. In 2013 a Delaware court decided In re Trados, a dispute over a $60 million sale in which most of the proceeds went to preferred stockholders through their preference and a management incentive plan, leaving common holders with nothing. The court held that directors owe their duties to common stockholders, found the process unfair, but found the price fair because the common was worth nothing either way. The terms had decided the outcome long before the sale.

What is a term sheet in venture capital?

A term sheet is a short summary of the principal terms of a financing. From the Series A onward, US rounds almost always use convertible preferred stock, documented in the NVCA model legal documents: the term sheet, the stock purchase agreement, the amended charter, the investors' rights agreement, the voting agreement, and the right-of-first-refusal and co-sale agreement.

Only a few clauses are legally binding at signing: confidentiality, the no-shop and expenses. The economic terms bind by reputation. Venture is a small, repeated game, and a firm that re-trades after signing damages itself with every founder who hears about it.

Before reading the clauses, understand the core asymmetry. Investors buy preferred stock; founders and employees hold common stock. The preferred carries a downside floor and governance rights. In a huge exit every investor converts to common and the extra rights disappear. So term negotiation is really a negotiation about the downside and the middle.

Step 1: Check the valuation and the option pool

The most negotiated sentence in a term sheet is usually the pre-money valuation, because of what it includes. Price per share equals the pre-money valuation divided by the fully diluted pre-money share count. If the new option pool, SAFEs and notes are counted in the pre-money, existing holders bear their dilution, not the new investor.

Investors typically require an unissued pool of about 10–15% after a Series A, created inside the pre-money. This is the "option pool shuffle." In the research companion's example, a $48 million headline pre-money with a 10% pool has an effective pre-money of about $43.2 million. The pool size is a valuation term in disguise.

How to read it:

• Find the pool target and ask whether it is in the pre-money or the post-money.
• Compare it with a bottom-up hiring plan for the next 18 to 24 months. An unallocated pool left over at the next round is wasted founder dilution.
• Check what converts in the pre-money: all SAFEs and notes usually do.

The scorecard for whether a round created value for existing holders is the step-up in price per share, not the headline valuation. In the book's two-round example, the price rises from $1.05 at seed to about $3.79 at Series A, a 3.61x step-up. A step-up of roughly 2–3x from seed to Series A is a common healthy range; below about 1.5x signals stress. The venture math and cap tables study has the full worked tables.

Step 2: Read the liquidation preference

The liquidation preference decides who gets paid first when the company is sold or wound down. It applies to a "deemed liquidation event," which covers mergers, asset sales and exclusive IP licenses, so it matters in an ordinary acquisition, not just a bankruptcy.

How does a liquidation preference work in practice?

Each non-participating series converts to common when its share of the proceeds beats its preference. The book's worked example uses a company with a $3 million seed and a $15 million Series A, both 1x non-participating, with the Series A senior:

At a $20 million sale, founders who own about half the company receive about $1.5 million. The Series A takes its $15 million flat across a wide range of prices; only above its own post-money valuation, $75 million here, does it convert. Over that flat zone the investor receives the same amount whatever the price, while every extra dollar goes to others. That is where incentives diverge, and where the Trados problem appears.

The research companion's three-series example makes the same point at larger scale. With a $2 million seed, $10 million Series A and $30 million Series B, a $60 million sale gives common holders, who own 50% of the fully diluted shares, only $16.67 million, or 28% of the proceeds. Any multiple preference, participation or accruing dividend widens that gap.

Step 3: Read anti-dilution and dividends

Anti-dilution protects investors in a down round by lowering their conversion price, so each preferred share converts into more common shares. The default is broad-based weighted average:

New conversion price = Old conversion price × (A + B) ÷ (A + C)

Here A is all common-equivalent shares outstanding, B is the shares the new money would buy at the old price, and C is the shares actually issued. In the research companion's example, a down round at $1.50 against a Series A price of $2.50 moves the Series A conversion price to $2.17 under broad-based weighted average, $1.93 under narrow-based, and $1.50 under a full ratchet. The Series A's ownership becomes 18.75%, 20.59% or 25.00%. The founders bear most of the difference. A full ratchet is rare and punitive; treat it as a red flag.

Dividends are usually non-cumulative, paid only "when, as and if declared," and in practice never paid. Cumulative or accruing dividends add to the preference every year and are a real economic term. Cooley reported them in about 3% of Q2 2026 deals.

Two more economic clauses deserve a look. Pay-to-play converts investors who do not take up their share of a later round into common; Cooley reported it in 8.4% of Q2 2026 deals, and founders tend to welcome it because it commits insiders. Redemption rights appeared in 5.4% of deals and are weak in practice, because Delaware law limits redemption to legally available funds.

Step 4: Read the control terms

The vetoes that matter are over a sale of the company, new senior securities and changes to board size. A veto over "any debt" or ordinary hiring is operational control by the back door; those decisions belong to the board. Ask for the preferred to vote together as one class rather than series by series, or each new series will gain its own veto over the next round or a sale.

Board seats can matter more than economics. In 2017 a dispute between Benchmark and Uber's founder over board-seat appointment rights granted in 2016 showed that voting agreements can decide who controls a company. The board work study covers how boards work after the round.

Step 5: Check the late-stage structure

At growth stage, when a company insists on a price investors do not believe, the gap is often closed with structure: senior or multiple preferences, participation, IPO ratchets, minimum-price conversion conditions or warrants. Two investors in the "same" $5 billion round can hold very different securities.

Square is the canonical example. Its 2014 Series E investors had an IPO ratchet. When the 2015 IPO priced at $9 against a Series E price of about $15.46, they reportedly received about 10 million additional shares. During 2022–24 many late-stage companies avoided headline down rounds by adding senior preferences, multiples, ratchets and warrants, and several had to recapitalize anyway.

Check the mandatory conversion clause, too. A minimum IPO price lets a late investor block a listing it does not like.

Step 6: Model it before you sign

The single most useful habit is to run the waterfall at three exit values before signing: a disappointing sale, a solid sale and a home run. Then convert every structural request into an equivalent valuation change in the middle case. "A 1.5x preference is worth about this many dollars of valuation in our base exit" is a negotiation; arguing about principles is not.

A short checklist:

1. What is the price per share after the pool and all converting instruments?
2. What does common receive at an exit equal to the post-money, half of it, and three times it?
3. Is anything participating, multiple, senior or accruing?
4. Which vetoes exist, and do they belong to the board instead?
5. Who controls the board after this round, and after the next?
6. Which terms will the next investor demand as a floor?

That last question matters because terms compound. A senior 2x preference at Series C invites the same at Series D, and the stack can crush common equity and employee motivation. In competitive markets clean terms are also a sourcing strategy for the best firms, because founders compare notes.

How the terms fit the four-factor view

The Outlier Equation treats a venture return as the product of four factors: creating an outlier, pricing it, governing it and turning it into cash. A term sheet is where price and governance are written down. In a home run, governance terms fade because everyone converts. In a total loss, nothing helps. In the middle, where most companies land, the preference stack and the vetoes decide whether founders and employees still have a reason to build. When the stack rises toward plausible sale values, the governance factor can fall to zero for common holders even though the company has real value.

Before the priced round, you may face a different set of instruments. Our comparison of SAFEs versus convertible notes covers them, and our guide to how to raise a seed round covers the earlier fundraise. For how term sheets fit into the venture system as a whole, see how venture capital works.

The takeaway

Read a term sheet as a payout table, not a valuation. Check the price per share after the option pool and conversions, model what common receives at low, middle and high exits, and confine investor vetoes to the decisions that truly belong to stockholders. Standard terms in 2026, 1x non-participating preferences, broad-based weighted average anti-dilution and a short veto list, exist because they work for both sides in most outcomes. Chapter 8 of The Outlier Equation covers term sheets and financing instruments in full, with worked waterfalls in its appendix.